Silvercrest Asset Management Group LLC Purchases 37,523 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Silvercrest Asset Management Group LLC raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 24.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 189,115 shares of the company's stock after purchasing an additional 37,523 shares during the quarter. Silvercrest Asset Management Group LLC owned about 1.25% of U.S. Physical Therapy worth $16,776,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wells Fargo & Company MN grew its holdings in shares of U.S. Physical Therapy by 2.2% during the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock worth $10,021,000 after buying an additional 2,465 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of U.S. Physical Therapy by 37.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock valued at $409,000 after buying an additional 1,254 shares during the period. Copeland Capital Management LLC grew its position in U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after acquiring an additional 72,715 shares in the last quarter. Proficio Capital Partners LLC bought a new stake in shares of U.S. Physical Therapy in the fourth quarter worth $3,526,000. Finally, Bridge City Capital LLC lifted its stake in U.S. Physical Therapy by 7.0% during the fourth quarter. Bridge City Capital LLC now owns 64,947 shares of the company's stock valued at $5,761,000 after purchasing an additional 4,235 shares during the last quarter.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. JMP Securities reiterated a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Finally, Barrington Research lowered their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Stock Performance

Shares of NYSE:USPH traded down $1.42 during trading on Thursday, hitting $75.86. 31,417 shares of the stock were exchanged, compared to its average volume of 110,743. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of 80.70, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $105.80. The company's fifty day simple moving average is $71.96 and its 200-day simple moving average is $83.49.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. During the same quarter in the previous year, the firm posted $0.51 EPS. The business's revenue for the quarter was up 18.0% on a year-over-year basis. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be paid a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.37%. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 2.00% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.